IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.

导出 LinkOut

翻译打印收藏纠错

第一作者： Elisa,Bergaggio

第一单位： Department of Molecular Biotechnology and Health Sciences and.

作者： Elisa,Bergaggio ^[1] ; Chiara,Riganti ^[2] ; Giulia,Garaffo ^[1] ; Nicoletta,Vitale ^[1] ; Elisabetta,Mereu ^[1] ; Cecilia,Bandini ^[3] ; Elisa,Pellegrino ^[1] ; Verdiana,Pullano ^[1] ; Paola,Omedè ^[4] ; Katia,Todoerti ^[3] ; Luciano,Cascione ^[5] ; Valentina,Audrito ^[6] ; Anna,Riccio ^[7] ; Antonio,Rossi ^[8] ; Francesco,Bertoni ^[5] ; Silvia,Deaglio ^[6] ; Antonino,Neri ^[3] ; Antonio,Palumbo ^[1] ; Roberto,Piva ^[1]

作者单位： Department of Molecular Biotechnology and Health Sciences and. ^[1] Department of Oncology, University of Torino, Torino, Italy. ^[2] Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.;Hematology Unit, Fondazione Cà Granda Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Maggiore Policlinico, Milano, Italy. ^[3] Città Della Salute e della Scienza Hospital, Torino, Italy. ^[4] Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland. ^[5] Department of Medical Sciences, University of Torino, Torino, Italy.;Italian Institute for Genomic Medicine, Torino, Italy. ^[6] Department of Biology, University of Rome Tor Vergata, Roma, Italy; and. ^[7] Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche, Roma, Italy. ^[8]